Implementing guidelines for the institutional use of factor VIIa (recombinant): a multidisciplinary solution.
Rudisill
Celeste N
CN
South Carolina College of Pharmacy, University of South Carolina, Columbia, SC 29208, USA. cnrudisill@gmail.com
Hockman
Rebecca H
RH
Degregory
Kathlene A
KA
Mutnick
Alan H
AH
Macik
Barbara Gail
BG
D003362:Cost-Benefit Analysis; D017723:Drug Utilization Review; D015942:Factor VIIa / Q000191:economics / Q000627:therapeutic use*; D005572:Formularies, Hospital as Topic; D006470:Hemorrhage / Q000188:drug therapy; D010607:Pharmacy Service, Hospital / Q000592:standards*; D010606:Pharmacy and Therapeutics Committee; D017410:Practice Guidelines as Topic; D011994:Recombinant Proteins / Q000191:economics / Q000627:therapeutic use*
D011994:Recombinant Proteins; D015942:Factor VIIa